美國居民不適用 XM 服務。

Hong Kong stocks gain further in longest rally since Jan 2018



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Hong Kong stocks gain further in longest rally since Jan 2018</title></head><body>

By Summer Zhen

HONG KONG, May 3 (Reuters) -Hong Kong stocks rise further on Friday, as market sentiment continued to improve, buoyed by China's stepped-up efforts to boost the economy.

The Hang Seng Index .HSI climbed 1.1% by midday, on track for a ninth consecutive day of gains and on its the longest winning streak since January 2018.

Chinese markets are closed for holidays from May 1-3.

China's politburo statement at the end of April "indicates a stronger commitment to a pro-growth and pro-reform policy agenda," said Jason Lui, head of APAC Equity and derivative strategy, BNP Paribas, adding the firm is upgrading their view on the MSCI China index .dMICN00000PUS.

Meanwhile, UBS says global hedge funds that use an equities long-short strategy are growing increasingly bullish on China, evidenced by the heavy pick-up in their purchases of Hong Kong-listed shares.

** By midday break, Chinese H-shares listed in Hong Kong .HSCE rose 1.29% to 6,520.05, while the Hang Seng Index .HSI was up 1.14% at 18,413.79.

** The sub-index of the Hang Seng index tracking energy shares .HSCIE rose 0.8% while the IT sector .HSCIIT rose 1.6%. The top gainer on the Hang Seng was NetEase Inc 9999.HK, up 4.53%, while the biggest loser was WuXi AppTec Co Ltd 2359.HK, which was down -5.82%.

** Around the region, MSCI's Asia ex-Japan stock index .MIAPJ0000PUS was firmer by 1.00% while Japan's Nikkei index .N225 was down 0.10%.



Reporting by Summer Zhen; Editing by Rashmi Aich

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明